Penicillin allergy de-labelling implementation intervention in a UK hospital: a process evaluation, the patient experience
JAC-Antimicrobial Resistance · 02.07.2025 · 7 (4)
DOI: 10.1093/jacamr/dlaf144 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAC-Antimicrobial Resistance, online erschienen am 13.08.2025. Verfasst von Neil Powell und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy Department, Royal Cornwall Hospital, Truro TR1 3LJ, UK. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Education England, National Institute for Health Research.
Abstract (Originalsprache)
Background
Penicillin allergy (penA) records are common, but true penA is rare. PenA records are associated with broad spectrum antibiotic prescribing and negative patient outcomes. We developed a behavioural intervention package to support inpatient penicillin allergy de-labelling (PADL) delivered by a multi-profession non-allergist workforce to remove incorrect penA records from medical and surgical adult inpatients in a UK hospital.
Aims
To explore the experiences, beliefs and concerns of patients who had been offered PADL.
Methods
Semi-structured interviews to explore the views of patients admitted to a medical or surgical ward with a penA record and offered PADL between June 2024 and October 2024. Inductive reflexive thematic analysis was used to analyse the data.
Results
Twenty patients were interviewed. Patients that believed their penA to be incorrect and those that described their index reaction as mild were more likely to agree to testing. Patients considered hospital a safe place to be tested. Some patients thought being acutely unwell was not a barrier to testing, whereas others preferred an outpatient setting once discharged from hospital. De-labelled patients described having a good explanation of the risks and benefits of PADL, were grateful for the opportunity and trusted the healthcare worker and the PADL process.
Conclusion
PADL was well accepted by patients who described receiving a good explanation of the PADL process. Index reactions perceived as low severity (e.g. non-severe rashes) and/or doubtful of their penA (e.g. unaware they had a penA record) were more likely to accept PADL. Some who declined inpatient PADL would consider outpatient testing once recovered from their acute illness.
Autor:innen und Institutionen
- Pharmacy Department, Royal Cornwall Hospital, Truro TR1 3LJ, UK.
- School of Biomedical Sciences, University of Plymouth, Plymouth PL4 8AA, UK.
- School of Biomedical Sciences, University of Plymouth, Plymouth, UK.
- School of Nursing and Midwifery, University of Plymouth, Plymouth, UK.
- Leeds Institute of Medical Research, University of Leeds, Leeds, UK.
- Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
ORCID-Profile: Neil Powell, Mathew Upton, Jonathan A T Sandoe, Sarah Tonkin-Crine
Förderung
- Health Education England
- National Institute for Health Research
Zitieren
APA
Powell, N., Upton, M., Kent, B., Sandoe, J. A. T., & Tonkin-Crine, S. (2025). Penicillin allergy de-labelling implementation intervention in a UK hospital: a process evaluation, the patient experience. JAC-Antimicrobial Resistance, 7(4). https://doi.org/10.1093/jacamr/dlaf144
Vancouver
Powell N, Upton M, Kent B, Sandoe JAT, Tonkin-Crine S. Penicillin allergy de-labelling implementation intervention in a UK hospital: a process evaluation, the patient experience. JAC-Antimicrobial Resistance. 2025;7(4). doi:10.1093/jacamr/dlaf144
BibTeX
@article{Powell2025,
author = {Powell, Neil and Upton, Mathew and Kent, Bridie and Sandoe, Jonathan A T and Tonkin-Crine, Sarah},
title = {Penicillin allergy de-labelling implementation intervention in a UK hospital: a process evaluation, the patient experience},
journal = {JAC-Antimicrobial Resistance},
year = {2025},
volume = {7},
number = {4},
doi = {10.1093/jacamr/dlaf144}
}
EUVIMED